Skip to main content
SpringerLink
Log in

Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer

  • Chapter
Book cover Gynecologic Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 95))

Abstract

Invasive cervical cancer is becoming a rare entity in the United States today. According to National Cancer Institute data, there were 15,800 new cases and 4800 deaths from cervical cancer in 1995 [1]. This is in stark contrast to the statistics from developing nations, where cervical cancer is still the most common malignancy in women. The relatively low incidence of cervical cancer in developed nations is largely attributable to the effectiveness of screening programs [2–5]. Cervical cancer screening today is synonymous with cervical cytologic, or Pap smear, screening. This method was developed to detect precursor lesions, known as cervical intraepithelial neoplasia or dysplasia, as well as early invasive cervical cancer, for which treatments are highly effective.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 429.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 549.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wingo PA, Tong T, Bolden S (1995) Cancer statistics, 1995. CA Cancer J Clin 45:8–30.

    Article  PubMed  CAS  Google Scholar 

  2. Johannesson G, Geirsson G, Day N (1978) The effect of mass screening in Iceland, 1965-70 on the incidence and mortality of cervical carcinoma. Int J Cancer 21:418–425.

    Article  PubMed  CAS  Google Scholar 

  3. Day NE (1984) Effect of cervical cancer screening in Scandinavia. Obstet Gynecol 63:714–718.

    PubMed  CAS  Google Scholar 

  4. Benedet JL, Anderson GH, Matisic JP (1992) A comprehensive program for cervical cancer detection and management. Am J Obstet Gynecol 166:1254–1259.

    PubMed  CAS  Google Scholar 

  5. Devesa SS, Silverman DT, Young JL Jr., et al. (1987) Cancer incidence and mortality trends among whites in the United States, 1947-84. J Natl Cancer Inst 79:701–770.

    PubMed  CAS  Google Scholar 

  6. The American Cancer Society guidelines for the cancer-related checkup. (1992) CA Cancer J Clin 42:44–45.

    Article  Google Scholar 

  7. (1989) The Papanicolaou test for cervical cancer detection: A triumph and a tragedy. JAMA 261:737-743.

    Google Scholar 

  8. Ayre JE (1947) Selective cytology smear for diagnosis of cancer. Am J Obstet Gynecol 53:609–617.

    PubMed  CAS  Google Scholar 

  9. Kivlahan C, Ingram E (1986) Papanicolaou smears without endocervical cells: Are they inadequate?. Acta Cytol 30:258–260.

    PubMed  CAS  Google Scholar 

  10. Boon M, de Graff-Guilloud J, Rietveld W (1989) Analysis of five sampling methods for the preparation of cervical smears. Acta Cytol 33:843–848.

    PubMed  CAS  Google Scholar 

  11. Alon-van Kordelaar J, Boon M (1988) Diagnostic accuracy of squamous cervical lesions studied in spatula-Cytobrush smears. Acta Cytol 32:801–840.

    Google Scholar 

  12. Kristensen GB, Holund B, Grinsted P (1989) Efficacy of the Cytobrush versus the cotton swab in the collection of endocervical cells. Acta Cytol 33:849–851.

    PubMed  CAS  Google Scholar 

  13. Mitchell H, Medley G (1991) Longitudinal study of women with negative cervical smears according to endocervical status: Victorian Cytology Service, Melbourne, Australia. Lancet 337:265–267.

    Article  PubMed  CAS  Google Scholar 

  14. Sedlis A, Walters AT, Balin H, Hontz A, Lo Sciuto L (1974) Evaluation of two simultaneously obtained cervical cytological smears: A comparison study. Acta Cytol 18:291–296.

    PubMed  CAS  Google Scholar 

  15. Davis JR, Hindman WM, Paplanus SH, Trego DC, Wiens JL, Suciu TN (1981) Value of duplicate smears in cervical cytology. Acta Cytol 25:533–538.

    PubMed  CAS  Google Scholar 

  16. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ (1992) Human papillomavirus infection of the cervix: Relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328–337.

    Article  PubMed  CAS  Google Scholar 

  17. Montz FJ, Bradley JM, Fowler JM, Nguyen L (1992) Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 80:385–388.

    PubMed  CAS  Google Scholar 

  18. Nasiell K, Roger V, Nasiell M (1986) Behavior of mild cervical dysplasia during long term follow-up. Obstet Gynecol 67:665–669.

    Article  PubMed  CAS  Google Scholar 

  19. Campion MJ, Cuzick J, McCance DJ, Singer A (1986) Progressive potential of mild cervical atypia: Prospective cytological, colposcopic, and virological study. Lancet 8501:237–240.

    Article  Google Scholar 

  20. Mango LJ (1994) Computer-assisted cervical cancer screening using neural networks. Cancer Letters 77:155–162.

    Article  PubMed  CAS  Google Scholar 

  21. Rilke F, Mango L, Alasio L (1993) Sensitivity of the PAPNET cytological screening system to a routine mixture of conventional smears (abstr). Mod Pathol 6:31.

    Google Scholar 

  22. Slagel DD, Zaleski S, Mango L, Cohen MB (1993) Evaluation of the PAPNET automated cytological screening system for gynecologic smears (abstr). Mod Pathol 6:32.

    Google Scholar 

  23. Greenberg MD, Campion MJ, Rutledge LH (1993) Cervicography as an adjunct to cytologic screening. Obstet Gynecol Clin North Am 20:13–29.

    PubMed  CAS  Google Scholar 

  24. Reid R, Greenberg MD, Lorincz A, et al. (1991) Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection?. Am J Obstet Gynecol 164:1461–1471.

    PubMed  CAS  Google Scholar 

  25. Massad LS, Lonky NM, Mutch DG, et al. (1993) Use of speculoscopy in the evaluation of women with atypical Papanicolaou smears: Improved cost effectiveness by selective colposcopy. J Reprod Med 38:163–169.

    PubMed  CAS  Google Scholar 

  26. Lonky NM, Mann WJ, Massad LS, et al. (1995) Ability of visual tests to predict underlying cervical neoplasia: Colposcopy and speculoscopy. J Reprod Med 40:530–536.

    PubMed  CAS  Google Scholar 

  27. National Cancer Institute Workshop (1989) The 1988 Bethesda system for reporting cervical/ vaginal cytological diagnoses. JAMA 262:931–934.

    Article  Google Scholar 

  28. Kurman RJ, Henson DE, Herbst AL, et al. (1994) Interim guidelines for management of abnormal cervical cytology. JAMA 271:1866–1869.

    Article  PubMed  CAS  Google Scholar 

  29. Young RC, Walton LA, Ellenberg SS, et al. (1990) Adjuvant therapy in stage I and stage II epithelial ovarian cancer: Results of two prospective randomized trials. N Engl J Med 322:1021–1027.

    Article  PubMed  CAS  Google Scholar 

  30. Pettersson F (1988) Annual report on the results of treatment in gynecological cancer, Vol. 20. Stockholm: International Federation of Gynecology and Obstetrics.

    Google Scholar 

  31. Cutler SJ, Young JL (1975) Third national cancer survey: Incidence data. Natl Cancer Inst Monogr 41:1–25.

    Google Scholar 

  32. Anderson M (1989) Malignant potential of benign ovarian cysts: The case ‘for.’ In: Sharp F, Mason W, Leake R, eds: Ovarian Cancer. London: Chapman and Hall, pp. 187–196.

    Google Scholar 

  33. Whittemore A, Harris R, Intyre J, et al. (1992) Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 U.S. case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 136:1184–1203.

    CAS  Google Scholar 

  34. Bast C, Feeney M, Lazarus H, et al. (1981) Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 68:1331–1337.

    Article  PubMed  Google Scholar 

  35. Bast R, Klug T, St John E, et al. (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 309:883–887.

    Article  PubMed  Google Scholar 

  36. Jacobs I, Bast R (1989) The CA125 tumour associated antigen: A review of the literature. Hum Reprod 4:1–12.

    Article  PubMed  CAS  Google Scholar 

  37. Zurawski R, Orjaseter H, Andersen A, et al. (1988) Elevated serum CA125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer. Int J Cancer 42:677–680.

    Article  PubMed  Google Scholar 

  38. Jacobs I, Bridges J, Reynolds C, et al. (1988) Multimodal approach to screening for ovarian cancer. Lancet 1:268–271.

    Article  PubMed  CAS  Google Scholar 

  39. Einhorn N, Sjovall K, Knapp R, et al. (1992) Prospective evaluation of CA125 levels for early detection of ovarian cancer. Obstet Gynecol 80:14–18.

    PubMed  CAS  Google Scholar 

  40. Jacobs I, Prys Davies A, Bridges J, et al. (1993) Prevalence screening for ovarian cancer in postmenopausal women by CA125 measurement and ultrasonography. Br Med J 306:1030–1034.

    Article  CAS  Google Scholar 

  41. Xu FJ, Yu YH, Li BY, et al. (1991) Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells. Cancer Res 51:4012–4019.

    PubMed  CAS  Google Scholar 

  42. Xu FJ, Yu YA, Daly L, et al. (1993) The OVX1 radioimmunoassay complements CA125 for predicting the presence of residual ovarian carcinoma at second look surgical surveillance procedures. J Clin Oncol 11:1506–1510.

    PubMed  CAS  Google Scholar 

  43. Woolas RP, Xu FJ, Jacobs IJ, et al. (1993) Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst 85:1748–1751.

    Article  PubMed  CAS  Google Scholar 

  44. Jacobs I (1994) Combinations of markers in screening for ovarian cancer. Int J Gynecol Obstet 46:83–86.

    Google Scholar 

  45. Campbell S, Bhan V, Reyston J, et al. (1989) Transabdominal ultrasound screening for early ovarian cancer. Br Med J 299:1363–1367.

    Article  CAS  Google Scholar 

  46. Timor-Tritsch I, Bar-Yam Y, Elgali S, et al. (1988) The technique of transvaginal sonography with the use of a 6.5 MHz probe. Am J Obstet Gynecol 158:1019–1024.

    PubMed  CAS  Google Scholar 

  47. van Nagell J, Higgins R, Donaldson E, et al. (1990) Transvaginal sonography as a screening method for ovarian cancer. Cancer 65:573–577.

    Article  PubMed  Google Scholar 

  48. van Nagell J, DePriest P, Puls L, et al. (1991) Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography. Cancer 68:458–462.

    Article  PubMed  Google Scholar 

  49. Bourne T, Whitehead M, Campbell S, et al. (1991) Ultrasound screening for familial ovarian cancer. Gynecol Oncol 43:92–97.

    Article  PubMed  CAS  Google Scholar 

  50. DePriest P, van Nagell J, Gallion H, et al. (1993) Ovarian cancer screening in asymptomatic postmenopausal women. Gynecol Oncol 51:205–209.

    Article  PubMed  CAS  Google Scholar 

  51. Folkman J (1991) What is the evidence that tumors are angiogenesis-dependent?. J Natl Cancer Inst 82:4–6.

    Article  Google Scholar 

  52. Kurjak A, Zalud I (1992) Transvaginal colour Doppler in the differentiation between benign and malignant ovarian masses. In: Sharp F, Mason W, Creasman W, eds. Ovarian Cancer, Vol 2. London: Chapman and Hall, pp. 249–264.

    Google Scholar 

  53. Kurjak A, Zalud I, Alfirevic Z (1991) Evaluation of adnexal masses with transvaginal color ultrasound. J Ultrasound Med 10:295–297.

    PubMed  CAS  Google Scholar 

  54. Bourne T, Campbell S, Reynolds K, et al. (1993) Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. Br Med J 306:1025–1029.

    Article  CAS  Google Scholar 

  55. Kramer BS, Gohagan J, Prorok PC, et al. (1993) A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers. Cancer 71:589–593.

    Article  PubMed  CAS  Google Scholar 

  56. Boronow RC (1976) Endometrial cancer: Not a benign disease. Obstet Gynecol 47:630–634.

    PubMed  CAS  Google Scholar 

  57. Mitchell H, Giles G, Medley G (1993) Accuracy and survival benefit of cytological prediction of endometrial carcinoma on routine cervical smears. Int J Gynecol Pathol 12:34–40.

    Article  PubMed  CAS  Google Scholar 

  58. Yancey M, Mageissen D, Demaurez A, et al. (1990) Classification of endometrial cells on cervical cytology. Obstet Gynecol 76:1000–1005.

    PubMed  CAS  Google Scholar 

  59. Chambers JT, Chambers SK (1992) Endometrial sampling: When? where? why? with what?. Clin Obstet Gynecol 35:28–39.

    Article  PubMed  CAS  Google Scholar 

  60. Bouchardy C, Vassilakos P, Riotton G (1987) Endometrial cytohistology by the pistol-aspiration technique: Clinical applicability. Obstet Gynecol 70:389–393.

    PubMed  CAS  Google Scholar 

  61. LoPolla J, Nicosia S, McCurdy C, et al. (1990) Experience with the Endo-Pap device for the cytologic detection of uterine cancer and its precursors: A comparison of the Endo-Pap with fractional curettage or hysterectomy. Am J Obstet Gynecol 163:1055–1059.

    Google Scholar 

  62. Goldstein SR, Nachtigall M, Snyder JR, et al. (1990) Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119–123.

    PubMed  CAS  Google Scholar 

  63. Granberg S, Wikland M, Karlsson B, et al. (1991) Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 164:47–52.

    PubMed  CAS  Google Scholar 

  64. Osmers R, Volksen M, Schauer A (1990) Vaginosonography for early detection of endometrial carcinoma?. Lancet 18:1569–1571.

    Article  Google Scholar 

  65. Kurjak A, Shalan H, Kupesic S, et al. (1994) An attempt to screen asymptomatic women for ovarian and endometrial cancer with transvaginal color and pulsed Doppler sonography. J Ultrasound Med 13:295–301.

    PubMed  CAS  Google Scholar 

  66. Shipley CF, Simmons CL, Nelson GH (1994) Comparison of transvaginal sonography with endometrial biopsy in asymptomatic postmenopausal women. J Ultrasound Med 13:99–104.

    PubMed  Google Scholar 

  67. Holbert TR (1994) Screening transvaginal ultrasonography of postmenopausal women in a private office setting. Am J Obstet Gynecol 170:1699–1704.

    PubMed  CAS  Google Scholar 

  68. Karlsson B, Granberg S, Wikland M, et al. (1995) Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding: A Nordic Multicenter study. Am J Obstet Gynecol 172:1488–1494.

    Article  PubMed  CAS  Google Scholar 

  69. Kurjak A, Shalan H, Sosic A, et al. (1993) Endometrial carcinoma in postmenopausal women: Evaluation by transvaginal color Doppler ultrasonography. Am J Obstet Gynecol 169:1597–1603.

    PubMed  CAS  Google Scholar 

  70. Varner RE, Sparks JM, Cameron CD, et al. (1991) Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 78:195–199.

    PubMed  CAS  Google Scholar 

  71. Weiner Z, Beck D, Rottem S, et al. (1993) Uterine artery flow velocity in waveforms and color flow imaging in women with perimenopausal and postmenopausal bleeding. Acta Obstet Gynecol Scand 72:162–166.

    Article  PubMed  CAS  Google Scholar 

  72. Bourne T, Campbell S, Steer C, et al. (1991) Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: A preliminary report. Gynecol Oncol 40:253–259.

    Article  PubMed  CAS  Google Scholar 

  73. Dorum A, Kristensen B, Langebrekke A, et al. (1993) Evaluation of endometrial thickness measured by endovaginal ultrasound in women with postmenopausal bleeding. Acta Obstet Gynecol Scand 72:116–119.

    Article  PubMed  CAS  Google Scholar 

  74. Smith P, Bakos O, Heimer G, et al. (1991) Transvaginal ultrasound for identifying endometrial abnormality. Acta Obstet Gynecol Scand 70:591–594.

    Article  PubMed  CAS  Google Scholar 

  75. Parsons A, Lense J (1993) Sonohysterography for endometrial abnormalities: Preliminary results. J Clin Ultrasound 21:87–95.

    Article  PubMed  CAS  Google Scholar 

  76. Fornander T, Cedermark B, Mattsson A, et al. (1989) Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1:117–120.

    Article  PubMed  CAS  Google Scholar 

  77. Fisher B, Costantino JP, Redmond CK, et al. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527–537.

    Article  PubMed  CAS  Google Scholar 

  78. Rutqvist LE, Johansson H, Signomklao T, et al. (1995) Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies: Stockholm Breast Cancer Study Group. J Natl Cancer Inst 87:645–651.

    Article  PubMed  CAS  Google Scholar 

  79. Goldstein SR (1994) Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 170:447–451.

    PubMed  CAS  Google Scholar 

  80. Ciatto S, Cecchini S, Bonardi R, et al. (1994) Ultrasonography surveillance of endometrium in breast cancer patients on adjuvant tamoxifen. Lancet 344:60.

    Article  PubMed  CAS  Google Scholar 

  81. Iveson TJ, Powles TJ, Tidy A, et al. (1994) Transvaginal ultrasound screening in premenopausal women on tamoxifen (abstr). Br J Cancer 71(Suppl 24):14.

    Google Scholar 

  82. Goldrath MH, Sherman AI (1985) Office hysteroscopy and suction curettage: Can we eliminate the hospital diagnostic dilatation and curettage?. Am J Obstet Gynecol 152:220–229.

    PubMed  CAS  Google Scholar 

  83. Gimpleson RJ, Rappold HO (1988) A comparative study between panoramic hysteroscopy with directed biopsies and dilation and curettage: A review of 276 cases. Am J Obstet Gynecol 158:489–492.

    Google Scholar 

  84. Iossa A, Cianferoni L, Ciatto S, et al. (1991) Hysteroscopy and endometrial cancer diagnosis: A review of 2007 consecutive examinations in self-referred patients. Tumori 77:479–483.

    PubMed  CAS  Google Scholar 

  85. Stovall T, Salomon S, Ling F (1989) Endometrial sampling prior to hysterectomy. Obstet Gynecol 73:405–409.

    PubMed  CAS  Google Scholar 

  86. Ferry J, Farnsworth A, Webster M, et al. (1993) The efficacy of the Pipelle endometrial biopsy in detecting endometrial carcinoma. Aust N Z J Obstet Gynecol 33:76–78.

    Article  CAS  Google Scholar 

  87. Stock R, Kanbour A (1975) Prehysterectomy curettage. Obstet Gynecol 45:537–541.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Young B. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kris Ghosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven Ainbinder
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jonathan S. Berek
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

    Robert F. Ozols M.D., Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kim, Y.B., Ghosh, K., Ainbinder, S., Berek, J.S. (1998). Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer. In: Ozols, R.F. (eds) Gynecologic Oncology. Cancer Treatment and Research, vol 95. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5447-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5447-9_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7487-9

  • Online ISBN: 978-1-4615-5447-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation